Apollo Hospital Indraprastha
| India | Thailand | Turkey | |
| Radiation therapy for kidney cancer | ≈ AUD $6,000 | ≈ AUD $13,600 | from AUD $7,200 |
| Radiation therapy for colorectal cancer | ≈ AUD $6,400 | ≈ AUD $10,700 | from AUD $7,200 |
| Proton-beam therapy | ≈ AUD $31,500 | ≈ AUD $54,500 | from AUD $35,800 |
| Nephrectomy with Da Vinci Robot | from AUD $10,500 | ≈ AUD $21,500 | from AUD $26,500 |
| Nephrectomy | from AUD $6,000 | ≈ AUD $17,200 | from AUD $9,500 |
No hidden fees – just official clinic prices. Pay at the clinic for Kidney cancer treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Kidney cancer treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Kidney cancer treatment journey.
Dr Shruti Kate was a consultant at the world-renowned Tata Memorial Hospital before joining HCG Manavata Cancer Centre to lead medical oncology cases.
Dr Sridhar P.S. is a senior radiation oncologist at HCG Manavata Cancer Centre, specialising in targeted therapies for renal tumours. He is a Diplomate of the National Board in radiotherapy and leads treatment planning for complex oncology cases.
Dr Chaitainya Borde has managed over 30,000 PET scans at HCG Manavata Cancer Centre – a high-volume hub for precise cancer staging.
Dr. Ravindra Tandale is a consultant at HCG Manavata Cancer Centre in Nashik. He specializes in anesthesia for surgical oncology, including breast, lung, and liver cancer procedures. Dr. Tandale holds MBBS and DA qualifications.
He works at HCG Manavata, a facility that treats 75,000 patients annually and holds NABL and NABH accreditations. Dr. Tandale manages anesthesia for various surgeries, including procedures for late-stage cancer. He also provides online consultations for preoperative care.
Kidney cancer treatment in India focuses on surgery, precision medicine, and ablation. Indian oncology centres prioritise nephron-sparing surgery to protect kidney function. Facilities like Apollo Hospital Indraprastha and Manipal Hospitals hold JCI and NABH accreditations. This ensures they meet international standards of care.
Bookimed Expert Insight: India is a global hub for robotic-assisted surgery due to high patient volumes. Dr Raj Nagarkar at HCG Manavata Cancer Centre has performed 50,000+ cancer surgeries. Indian surgical teams often handle complex cases that smaller international centres might decline.
Patient Consensus: Patients note that clarifying whether the surgery is partial or radical is essential. Those with advanced cancer in India found targeted therapy was the main non-surgical recommendation.
Indian medical centres report an overall 77% 5-year survival rate for renal cell carcinoma after surgery. Early-stage outcomes reach 90.87% success for low-grade tumours. Leading facilities in Delhi and Bengaluru use Da Vinci robotics and CyberKnife systems. These achieve clinical results comparable to global averages.
Bookimed Expert Insight: Patient volume is a major indicator of surgical proficiency in India. HCG Manavata Cancer Centre serves 75,000 patients annually. Prof. Dr Raj Nagarkar there has performed over 50,000 cancer surgeries. This high repetition helps specialists manage complex renal cases requiring precise organ-sparing techniques.
Patient Consensus: Patients highlight the need to verify radiological response and recovery times. They recommend focusing on pathology stage and follow-up length for insight into long-term outcomes.
Patients can live a normal life with one kidney after cancer surgery in India. The remaining kidney naturally adapts to handle up to 75% of the body's total filtration needs. No dialysis is typically required if the remaining organ is healthy and cancer-free.
Bookimed Expert Insight: Manipal Goa Hospital and Global Hospital Chennai provide high-tier infrastructure for renal care. These facilities specialise in complex combined transplants and minimally invasive surgery. Patients benefit from research centres at hubs like Medanta that focus on organ preservation.
Patient Consensus: Individuals report a smooth transition back to work and travel after recovery. Most emphasise staying hydrated in hot weather. They also avoid specific pain relief drugs like ibuprofen to protect their kidney.
Chemotherapy is not a standard treatment for kidney cancer in India. Indian oncologists follow global protocols that prioritise surgery, immunotherapy, and targeted drugs. Most kidney tumours are resistant to chemo. JCI-accredited clinics like Apollo Hospital Indraprastha instead use robotic surgery and precision radiation.
Bookimed Expert Insight: Indian oncology centres often provide access to academic research through clinical trials. Prof. Dr Raj Nagarkar at HCG Manavata has participated in 200 trials. This is vital because trials provide access to new drugs when standard therapies fail.
Patient Consensus: Patients note that surgery is the primary treatment in India for localised disease. Most discussions focus on confirming if a tumour is renal cell carcinoma before choosing treatment.